Clinical Trial Update: TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating TracelT Hydrogel for localizing bladder tumors in patients undergoing radiation therapy for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Carcinoma

Drugs mentioned

• TracelT Hydrogel

Snippet

Sponsor: University of Washington | Conditions: Bladder Carcinoma | NA | Status: COMPLETED | Results posted: 2021-02-25